-InterdisciplinaryThe European Parliament Adopts Position on the European Commission’s Proposal for the First Major Overhaul of the EU Medicines Regulatory Framework in 20 Years April 24, 2024
-InterdisciplinaryJanssen v. Teva: Not an April Fool’s Day Joke for Life Sciences Companies April 10, 2024
-InterdisciplinaryA Look Ahead in Life Sciences: What We Are Tracking in Q2 2024 and Beyond April 2, 2024
-InterdisciplinaryUSPTO Emphasizes Searches of FDA Databases for Pharmaceutical Patent Applications March 29, 2024
-Interdisciplinary2023-2024 Key Trends and Updates: Securities Litigation Against Life Sciences Companies Webinar March 26, 2024
-InterdisciplinaryFDA’s Laboratory Developed Test (LDT) Final Rule Under OIRA Review; Subcommittee on Health to Hold Hearing on Regulation of Diagnostic Tests March 16, 2024
-InterdisciplinaryUSPTO’s New Guidance on AI-Assisted Inventions: The Impact on the Use of AI in the Life Sciences March 15, 2024